Diabetes drug alters vitamin D levels, possibly explaining increased bone fracture risk
Scientists found that the diabetes drug canagliflozin reduces vitamin D levels and calcium uptake, which may explain why this drug can increase the risk of bone fractures.
Source: NIDDK News - Category: Endocrinology Source Type: news
More News: Calcium | Canagliflozin | Diabetes | Endocrinology | Invokana | Orthopaedics | Vitamin D | Vitamins